Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Short telomere length and breast cancer risk: a study in sister sets.

Shen J, Terry MB, Gurvich I, Liao Y, Senie RT, Santella RM.

Cancer Res. 2007 Jun 1;67(11):5538-44.

2.

Genetic variation in telomere maintenance genes, telomere length and breast cancer risk.

Shen J, Terry MB, Liao Y, Gurvich I, Wang Q, Senie RT, Santella RM.

PLoS One. 2012;7(9):e44308. doi: 10.1371/journal.pone.0044308. Epub 2012 Sep 6.

3.

Telomere dysfunction: a potential cancer predisposition factor.

Wu X, Amos CI, Zhu Y, Zhao H, Grossman BH, Shay JW, Luo S, Hong WK, Spitz MR.

J Natl Cancer Inst. 2003 Aug 20;95(16):1211-8.

PMID:
12928346
4.

Longer relative telomere length in blood from women with sporadic and familial breast cancer compared with healthy controls.

Gramatges MM, Telli ML, Balise R, Ford JM.

Cancer Epidemiol Biomarkers Prev. 2010 Feb;19(2):605-13. doi: 10.1158/1055-9965.EPI-09-0896.

5.

Telomere length, oxidative damage, antioxidants and breast cancer risk.

Shen J, Gammon MD, Terry MB, Wang Q, Bradshaw P, Teitelbaum SL, Neugut AI, Santella RM.

Int J Cancer. 2009 Apr 1;124(7):1637-43. doi: 10.1002/ijc.24105.

6.

Telomere length in peripheral blood and breast cancer risk in a prospective case-cohort analysis: results from the Sister Study.

Kim S, Sandler DP, Carswell G, De Roo LA, Parks CG, Cawthon R, Weinberg CR, Taylor JA.

Cancer Causes Control. 2011 Jul;22(7):1061-6. doi: 10.1007/s10552-011-9778-8. Epub 2011 Jun 5.

7.

Constitutional short telomeres are strong genetic susceptibility markers for bladder cancer.

Broberg K, Björk J, Paulsson K, Höglund M, Albin M.

Carcinogenesis. 2005 Jul;26(7):1263-71. Epub 2005 Mar 3.

PMID:
15746160
8.

Chromosome 9 arm-specific telomere length and breast cancer risk.

Zheng YL, Loffredo CA, Shields PG, Selim SM.

Carcinogenesis. 2009 Aug;30(8):1380-6. doi: 10.1093/carcin/bgp151. Epub 2009 Jun 17.

9.

Telomere length and the risk of lung cancer.

Jang JS, Choi YY, Lee WK, Choi JE, Cha SI, Kim YJ, Kim CH, Kam S, Jung TH, Park JY.

Cancer Sci. 2008 Jul;99(7):1385-9. doi: 10.1111/j.1349-7006.2008.00831.x. Epub 2008 Apr 29.

10.

Association of leukocyte telomere length with breast cancer risk: nested case-control findings from the Shanghai Women's Health Study.

Qu S, Wen W, Shu XO, Chow WH, Xiang YB, Wu J, Ji BT, Rothman N, Yang G, Cai Q, Gao YT, Zheng W.

Am J Epidemiol. 2013 Apr 1;177(7):617-24. doi: 10.1093/aje/kws291. Epub 2013 Feb 25.

11.

A prospective study of relative telomere length and postmenopausal breast cancer risk.

De Vivo I, Prescott J, Wong JY, Kraft P, Hankinson SE, Hunter DJ.

Cancer Epidemiol Biomarkers Prev. 2009 Apr;18(4):1152-6. doi: 10.1158/1055-9965.EPI-08-0998. Epub 2009 Mar 17.

12.

Telomere length, cigarette smoking, and bladder cancer risk in men and women.

McGrath M, Wong JY, Michaud D, Hunter DJ, De Vivo I.

Cancer Epidemiol Biomarkers Prev. 2007 Apr;16(4):815-9.

13.

Telomere length in peripheral blood leukocytes is associated with risk of colorectal cancer in Chinese population.

Qin Q, Sun J, Yin J, Liu L, Chen J, Zhang Y, Li T, Shi Y, Wei S, Nie S.

PLoS One. 2014 Feb 3;9(2):e88135. doi: 10.1371/journal.pone.0088135. eCollection 2014.

14.

Telomere deficiencies on chromosomes 9p, 15p, 15q and Xp: potential biomarkers for breast cancer risk.

Zheng YL, Zhou X, Loffredo CA, Shields PG, Sun B.

Hum Mol Genet. 2011 Jan 15;20(2):378-86. doi: 10.1093/hmg/ddq461. Epub 2010 Oct 18.

15.

Telomere length in prospective and retrospective cancer case-control studies.

Pooley KA, Sandhu MS, Tyrer J, Shah M, Driver KE, Luben RN, Bingham SA, Ponder BA, Pharoah PD, Khaw KT, Easton DF, Dunning AM.

Cancer Res. 2010 Apr 15;70(8):3170-6. doi: 10.1158/0008-5472.CAN-09-4595.

16.

Telomere length and pancreatic cancer: a case-control study.

Skinner HG, Gangnon RE, Litzelman K, Johnson RA, Chari ST, Petersen GM, Boardman LA.

Cancer Epidemiol Biomarkers Prev. 2012 Nov;21(11):2095-100. doi: 10.1158/1055-9965.EPI-12-0671. Epub 2012 Oct 23.

17.

No association between TERT-CLPTM1L single nucleotide polymorphism rs401681 and mean telomere length or cancer risk.

Pooley KA, Tyrer J, Shah M, Driver KE, Leyland J, Brown J, Audley T, McGuffog L, Ponder BA, Pharoah PD, Easton DF, Dunning AM.

Cancer Epidemiol Biomarkers Prev. 2010 Jul;19(7):1862-5. doi: 10.1158/1055-9965.EPI-10-0281. Epub 2010 Jun 22.

18.

Telomere length in blood cells and breast cancer risk: investigations in two case-control studies.

Zheng YL, Ambrosone C, Byrne C, Davis W, Nesline M, McCann SE.

Breast Cancer Res Treat. 2010 Apr;120(3):769-75. doi: 10.1007/s10549-009-0440-z. Epub 2009 Jun 19.

19.

Breast cancer survival is associated with telomere length in peripheral blood cells.

Svenson U, Nordfjäll K, Stegmayr B, Manjer J, Nilsson P, Tavelin B, Henriksson R, Lenner P, Roos G.

Cancer Res. 2008 May 15;68(10):3618-23. doi: 10.1158/0008-5472.CAN-07-6497.

20.

Leukocyte telomere length in a population-based case-control study of ovarian cancer: a pilot study.

Mirabello L, Garcia-Closas M, Cawthon R, Lissowska J, Brinton LA, Pepłońska B, Sherman ME, Savage SA.

Cancer Causes Control. 2010 Jan;21(1):77-82. doi: 10.1007/s10552-009-9436-6. Epub 2009 Sep 27.

Supplemental Content

Support Center